Market Research Logo

Biologics Global Market Report 2018 Including: Therapeutic Proteins; Monoclonal Antibodies (MAbS); VaccinesCovering: Amgen,AbbVie Inc,Johnson & Johnson,Bristol-Myers Squibb Company,Pfizer Inc

Biologics Global Market Report 2018 Including: Therapeutic Proteins; Monoclonal Antibodies (MAbS); VaccinesCovering: Amgen,AbbVie Inc,Johnson & Johnson,Bristol-Myers Squibb Company,Pfizer Inc

Biologics Market Global Report 2018 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global biologics market.

Reasons to Purchase

Outperform competitors using accurate up to date demand-side dynamics information.

Identify growth segments for investment.

Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.

Create regional and country strategies on the basis of local data and analysis.

Stay abreast of the latest customer and market research findings

Benchmark performance against key competitors.

Develop strategies based on likely future developments.

Utilize the relationships between key data sets for superior strategizing.

Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Gain a global perspective on the development of the market.

Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider Healthcare market, and compares it with other markets.

The market characteristics section of the report defines and explains the market.

The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down market into sub markets.

The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

The biologics market section of the report gives context. It compares the biologics market with other segments of the Healthcare market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Biologics Indicators Comparison.

Scope

Markets Covered: Therapeutic Proteins; Monoclonal Antibodies (MAbS); Vaccines

Companies Mentioned: Amgen,AbbVie Inc,Johnson & Johnson,Bristol-Myers Squibb Company,Pfizer Inc

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Biologics Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Biologics Market Characteristics
2. Biologics Market Size And Growth
2.1. Historic Market Growth, Value ($ Billion) and Volume (Million Units)
2.1.1. Drivers Of The Market
2.1.2. Restraints On The Market
2.2. Forecast Market Growth, Value ($ Billion)
2.2.1. Drivers Of The Market
2.2.2. Restraints On The Market;
3. Biologics Trends And Strategies;
4. Pestle Analysis
4.1. Political
4.2. Economic
4.3. Social
4.4. Technological
4.5. Legal
4.6. Environmental;
5. Biologics Market Customer Information;
6. Biologics Market Regional And Country Analysis
6.1. Global Biologics Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
6.2. Global Biologics Market, 2013 - 2021, Historic And Forecast, By Region
6.3. Global Biologics Market, Growth And Market Share Comparison, By Region
6.4. Global Biologics Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
6.5. Global Biologics Market, 2013 - 2021, Historic And Forecast, By Country
6.6. Global Biologics Market, Growth And Market Share Comparison, By Country
7. Biologics Market Segmentation
7.1. Global Biologics Market, 2017, Segmentation By Type, Value ($ Billion)
Therapeutic Proteins
Monoclonal Antibodies (MAbS)
Vaccines
7.2. Global Biologics Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
8. Biologics Market Segments
8.1.Therapeutic Proteins
a) Market Characteristics
b) Market Trends & Strategies
c) Global Therapeutic Proteins Market, 2017, By Segment, Value ($ Billion)
d) Global Therapeutic Proteins Market, 2013 - 2021, Historic And Forecast, By Segment
8.2.Monoclonal Antibodies (MAbS)
a) Market Characteristics
b) Market Trends & Strategies
c) Global Monoclonal Antibodies (MAbS) Market, 2017, By Segment, Value ($ Billion)
d) Global Monoclonal Antibodies (MAbS) Market, 2013 - 2021, Historic And Forecast, By Segment
8.3.Vaccines
a) Market Characteristics
b) Market Trends & Strategies
c) Global Vaccines Market, 2017, By Segment, Value ($ Billion)
d) Global Vaccines Market, 2013 - 2021, Historic And Forecast, By Segment
9. Global Biologics Market Comparison With Macro Economic Factors
9.1. Biologics Market Size, Percentage Of GDP, Global
9.2. Per Capita Average Biologics Expenditure, Global
10. Biologics Market Comparison With Macro Economic Factors Across Countries
10.1. Biologics Market Size, Percentage Of GDP, By Country
10.2. Per Capita Average Biologics Expenditure, By Country
11. Biologics Market Comparison With Industry Metrics
11.1. Global Number Of Pharmacists, 2016, By Country
11.2. Global Biologics Market Revenue Versus Number Of Pharmacists, 2016, By Country
11.3. Global Number Of Pharma Enterprises, 2016, By Country
11.4. Global Biologics Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country
11.5. Global Number Of Employees In Pharmaceutical Industry, 2016, By Country
11.6. Global Biologics Market Revenue Versus Number Of Employees In Pharmaceutical Industry, 2016, By Country
11.7. Global Average Spending On R&D/Product Development, 2016, By Country
11.8. Global Biologics Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country
11.9. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country
11.1. Global Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country
11.11. Global Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2016, By Country
11.12. Global Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2016, By Country
11.13. Global Number Of Pharmacies, 2016, By Country
11.14. Global Biologics Market Revenue Versus Number Of Pharmacies, 2016, By Country
11.15. Global New Drug Approvals, 2016, By Country
11.16. Global Biologics Market Revenue Versus New Drug Approvals, 2016, By Country
11.17. Prevalent Cases Of Thalassemia, 2014, By Country
11.18. Global Number Of General Practitioners 2016, By Country
11.19. Global Biologics Market Revenue Versus Number Of General Practitioners, 2016, By Country
12. Asia-Pacific Biologics Market
12.1.1. Asia-Pacific Biologics Market Overview
12.1.2. Asia-Pacific Biologics Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
12.1.3. Asia-Pacific Biologics Forecast Market, 2017 - 2021, Value ($ Billion)
12.1.4. Asia-Pacific Biologics Market, 2017, Segmentation By Type, Value ($ Billion)
Therapeutic Proteins
Monoclonal Antibodies (MAbS)
Vaccines
12.1.5. Asia-Pacific Biologics Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
12.2. Asia-Pacific Biologics Market: Country Analysis
12.3. China Biologics Market
12.3.1. China Biologics Market Overview
12.3.2. China Biologics Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
12.3.3. China Biologics Forecast Market, 2017 - 2021, Value ($ Billion)
12.3.4. China Biologics Market, 2017, Segmentation By Type, Value ($ Billion)
Therapeutic Proteins
Monoclonal Antibodies (MAbS)
Vaccines
12.3.5. China Biologics Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
12.3.6.1. China Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2012 - 2016
12.3.6.2. China Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2012 - 2016
12.3.7.1. China Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2012 - 2016
12.3.7.2. China Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2012 - 2016
12.4. India Biologics Market
12.4.1. India Biologics Market Overview
12.4.2. India Biologics Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
12.4.3. India Biologics Forecast Market, 2017 - 2021, Value ($ Billion)
12.4.4. India Biologics Market, 2017, Segmentation By Type, Value ($ Billion)
Therapeutic Proteins
Monoclonal Antibodies (MAbS)
Vaccines
12.4.5. India Biologics Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
12.5. Japan Biologics Market
12.5.1. Japan Biologics Market Overview
12.5.2. Japan Biologics Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
12.5.3. Japan Biologics Forecast Market, 2017 - 2021, Value ($ Billion)
12.5.4. Japan Biologics Market, 2017, Segmentation By Type, Value ($ Billion)
Therapeutic Proteins
Monoclonal Antibodies (MAbS)
Vaccines
12.5.5. Japan Biologics Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
12.5.6. Japan Biologics Market Comparison With Industry Metrics
12.5.6.1. Japan Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2012 - 2016
12.5.6.2. Japan Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2012 - 2016
12.5.7. Japan Biologics Market Comparison With Industry Metrics
12.5.7.1. Japan Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2012 - 2016
12.5.7.2. Japan Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2012 - 2016
12.6. Australia Biologics Market
12.6.1. Australia Biologics Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
12.6.2. Australia Biologics Forecast Market, 2017 - 2021, Value ($ Billion)
12.6.3. Australia Biologics Market, 2017, Segmentation By Type, Value ($ Billion)
Therapeutic Proteins
Monoclonal Antibodies (MAbS)
Vaccines
12.6.4. Australia Biologics Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13. Western Europe Biologics Market
13.1.1. Western Europe Biologics Market Overview
13.1.2. Western Europe Biologics Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
13.1.3. Western Europe Biologics Forecast Market, 2017 - 2021, Value ($ Billion)
13.1.4. Western Europe Biologics Market, 2017, Segmentation By Type, Value ($ Billion)
Therapeutic Proteins
Monoclonal Antibodies (MAbS)
Vaccines
13.1.5. Western Europe Biologics Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.2. Western Europe Biologics Market: Country Analysis
13.3. UK Biologics Market
13.3.1. UK Biologics Market Overview
13.3.2. UK Biologics Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
13.3.3. UK Biologics Forecast Market, 2017 - 2021, Value ($ Billion)
13.3.4. UK Biologics Market, 2017, Segmentation By Type, Value ($ Billion)
Therapeutic Proteins
Monoclonal Antibodies (MAbS)
Vaccines
13.3.5. UK Biologics Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.3.6. UK Biologics Market Comparison With Industry Metrics
13.3.6.1. UK Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2012 - 2016
13.3.6.2. UK Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2012 - 2016
13.4. Germany Biologics Market
13.4.1. Germany Biologics Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
13.4.2. Germany Biologics Forecast Market, 2017 - 2021, Value ($ Billion)
13.4.3. Germany Biologics Market, 2017, Segmentation By Type, Value ($ Billion)
Therapeutic Proteins
Monoclonal Antibodies (MAbS)
Vaccines
13.4.4. Germany Biologics Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.4.5. Germany Biologics Market Comparison With Industry Metrics
13.4.5.1. Germany Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2012 - 2016
13.4.5.2. Germany Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2012 - 2016
13.5 France Biologics Market
13.5.1 France Biologics Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
13.5.2 France Biologics Forecast Market, 2017 - 2021, Value ($ Billion)
13.5.3. France Biologics Market, 2017, Segmentation By Type, Value ($ Billion)
Therapeutic Proteins
Monoclonal Antibodies (MAbS)
Vaccines
13.5.4. France Biologics Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.5.5. France Biologics Market Comparison With Industry Metrics
13.5.5.1. France Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2012 - 2016
13.5.5.2. France Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2012 - 2016
13.5.6. France Biologics Market Comparison With Industry Metrics
13.5.6.1. France Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2012 - 2016
13.5.6.2. France Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2012 - 2016
13.6. Italy Biologics Market
13.6.1. Italy Biologics Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
13.6.2. Italy Biologics Forecast Market, 2017 - 2021, Value ($ Billion)
13.6.3. Italy Biologics Market, 2017, Segmentation By Type, Value ($ Billion)
Therapeutic Proteins
Monoclonal Antibodies (MAbS)
Vaccines
13.6.4. Italy Biologics Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.6.5. Italy Biologics Market Comparison With Industry Metrics
13.6.5.1. Italy Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2012 - 2016
13.6.5.2. Italy Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2012 - 2016
13.7. Spain Biologics Market
13.7.1. Spain Biologics Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
13.7.2. Spain Biologics Forecast Market, 2017 - 2021, Value ($ Billion)
13.7.3. Spain Biologics Market, 2017, Segmentation By Type, Value ($ Billion)
Therapeutic Proteins
Monoclonal Antibodies (MAbS)
Vaccines
13.7.4. Spain Biologics Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.7.5. Spain Biologics Market Comparison With Industry Metrics
13.7.5.1. Spain Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2012 - 2016
13.7.5.2. Spain Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2012 - 2016
14. Eastern Europe Biologics Market
14.1.1. Eastern Europe Biologics Market Overview
14.1.2. Eastern Europe Biologics Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
14.1.3. Eastern Europe Biologics Forecast Market, 2017 - 2021, Value ($ Billion)
14.1.4. Eastern Europe Biologics Market, 2017, Segmentation By Type, Value ($ Billion)
Therapeutic Proteins
Monoclonal Antibodies (MAbS)
Vaccines
14.1.5. Eastern Europe Biologics Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
14.2. Eastern Europe Biologics Market: Country Analysis
14.3. Russia Biologics Market
14.3.1. Russia Biologics Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
14.3.2. Russia Biologics Forecast Market, 2017 - 2021, Value ($ Billion)
14.3.3. Russia Biologics Market, 2017, Segmentation By Type, Value ($ Billion)
Therapeutic Proteins
Monoclonal Antibodies (MAbS)
Vaccines
14.3.4. Russia Biologics Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
15. North America Biologics Market
15.1.1. North America Biologics Market Overview
15.1.2. North America Biologics Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
15.1.3. North America Biologics Forecast Market, 2017 - 2021, Value ($ Billion)
15.1.4. North America Biologics Market, 2017, Segmentation By Type, Value ($ Billion)
Therapeutic Proteins
Monoclonal Antibodies (MAbS)
Vaccines
15.1.5. North America Biologics Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
15.2. North America Biologics Market: Country Analysis
15.3. USA Biologics Market
15.3.1. USA Biologics Market Overview
15.3.2. USA Biologics Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
15.3.3. USA Biologics Forecast Market, 2017 - 2021, Value ($ Billion)
15.3.4. USA Biologics Market, 2017, Segmentation By Type, Value ($ Billion)
Therapeutic Proteins
Monoclonal Antibodies (MAbS)
Vaccines
15.3.5. USA Biologics Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
15.3.6. USA Biologics Market Comparison With Industry Metrics
15.3.6.1. USA Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2012 - 2016
15.3.6.2. USA Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2012 - 2016
16. South America Biologics Market
16.1.1. South America Biologics Market Overview
16.1.2. South America Biologics Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
16.1.3. South America Biologics Forecast Market, 2017 - 2021, Value ($ Billion)
16.1.4. South America Biologics Market, 2017, Segmentation By Type, Value ($ Billion)
Therapeutic Proteins
Monoclonal Antibodies (MAbS)
Vaccines
16.1.5. South America Biologics Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
16.2. South America Biologics Market: Country Analysis
16.3. Brazil Biologics Market
16.3.1. Brazil Biologics Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
16.3.2. Brazil Biologics Forecast Market, 2017 - 2021, Value ($ Billion)
16.3.3. Brazil Biologics Market, 2017, Segmentation By Type, Value ($ Billion)
Therapeutic Proteins
Monoclonal Antibodies (MAbS)
Vaccines
16.3.4. Brazil Biologics Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
17. Middle East Biologics Market
17.1.1. Middle East Biologics Market Overview
17.1.2. Middle East Biologics Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
17.1.3. Middle East Biologics Forecast Market, 2017 - 2021, Value ($ Billion)
17.1.4. Middle East Biologics Market, 2017, Segmentation By Type, Value ($ Billion)
Therapeutic Proteins
Monoclonal Antibodies (MAbS)
Vaccines
17.1.5. Middle East Biologics Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
18. Africa Biologics Market
18.1.1. Africa Biologics Market Overview
18.1.2. Africa Biologics Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
18.1.3. Africa Biologics Forecast Market, 2017 - 2021, Value ($ Billion)
18.1.4. Africa Biologics Market, 2017, Segmentation By Type, Value ($ Billion)
Therapeutic Proteins
Monoclonal Antibodies (MAbS)
Vaccines
18.1.5. Africa Biologics Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
19. Biologics Market Competitive Landscape
19.1. Company Profiles
19.2. Amgen
19.2.1. Overview
19.2.2. Products And Services
19.2.3. Strategy
19.2.4. Financial Performance
19.3. AbbVie Inc
19.3.1. Overview
19.3.2. Products And Services
19.3.3. Strategy
19.3.4. Financial Performance
19.4. Johnson & Johnson
19.4.1. Overview
19.4.2. Products And Services
19.4.3. Strategy
19.4.4. Financial Performance
19.5. Bristol-Myers Squibb Company
19.5.1. Overview
19.5.2. Products And Services
19.5.3. Strategy
19.5.4. Financial Performance
19.6. Pfizer Inc
19.6.1. Overview
19.6.2. Products And Services
19.6.3. Strategy
19.6.4. Financial Performance
20. Key Mergers And Acquisitions In The Biologics Market
21. Market Background: Healthcare Market
21.1.1. Healthcare Market Characteristics
21.1.2. Healthcare Market Historic Growth, Value ($ Billion)
21.1.2.1. Drivers Of The Market
21.1.2.2. Restraints Of The Market
21.1.3. Healthcare Market Forecast Growth, Value ($ Billion)
21.1.3.1. Drivers Of The Market
21.1.3.2. Restraints Of The Market
21.1.4. Healthcare Trends And Strategies
21.2. Healthcare Market Regional And Country Analysis
21.2.1. Global Healthcare Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
21.2.2. Global Healthcare Market, 2013 - 2021, Historic And Forecast, By Region
21.2.3. Healthcare Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
21.2.4. Healthcare Market, 2013 - 2021, Historic And Forecast, By Country
21.2.5. Healthcare Market, Growth And Market Share Comparison, By Segment
21.2.6. Healthcare Market, Growth And Market Share Comparison, By Country And Segment
21.3. Global Healthcare Market Comparison With Macro Economic Factors
21.3.1. Healthcare Market Size, Percentage Of GDP, Global
21.3.2. Per Capita Average Healthcare Expenditure, Global
21.4. Healthcare Market Comparison With Macro Economic Factors Across Countries
21.4.1. Healthcare Market Size, Percentage Of GDP, By Country
21.4.2. Per Capita Average Healthcare Expenditure, By Country
21.5. Key Mergers And Acquisitions In The Healthcare Market
22. Appendix
22.1. NAICS Definitions Of Industry Covered In This Report
22.2. Abbreviations
22.3. Currencies
22.4. Research Inquiries
22.5. The Business Research Company
22.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report